Magdalena Ocvirk

Title: The Innovative Contributions of Magdalena Ocvirk

Introduction

Magdalena Ocvirk is a notable inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on ergoline derivatives. With a total of 2 patents, her inventions have the potential to impact the treatment of psychosis.

Latest Patents

Ocvirk's latest patents include "Ergoline derivatives of 1-propinylamine, a process for the manufacture" and "Ergoline derivatives of 2-propinylamine, a process for the manufacture." The first patent describes a method of treating psychosis by administering an antipsychotically effective amount of an ergolinyl derivative of 2-propinylamine. This involves a complex formula where R1, R2, and R3 can represent various alkyl groups, while X and Z denote specific atoms and groups. The second patent focuses on novel ergoline derivatives of 2-propinylamine, detailing their general formula and potential applications.

Career Highlights

Throughout her career, Magdalena Ocvirk has worked with prominent companies such as Lek and Tovarna Farmacevtskih in Kemicnih. Her experience in these organizations has allowed her to develop her expertise in pharmaceutical innovations.

Collaborations

Ocvirk has collaborated with notable colleagues, including Bogomila Lavric and Rudolf Rucman. These partnerships have likely contributed to her success and the advancement of her research.

Conclusion

Magdalena Ocvirk's work exemplifies the spirit of innovation in the pharmaceutical industry. Her patents on ergoline derivatives highlight her commitment to improving mental health treatments. Through her career and collaborations, she continues to make a significant impact in her field.